Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Puretech Health Plc ADR
(NQ:
PRTC
)
27.64
-1.15 (-3.99%)
Streaming Delayed Price
Updated: 9:30 AM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Puretech Health Plc ADR
< Previous
1
2
3
4
5
6
7
Next >
Vedanta Biosciences Presents New Data from Phase 1 Study of VE202, Its Rationally-Defined Consortium for the Treatment of Inflammatory Bowel Disease, at the International Human Microbiome Consortium Congress 2021 (IHMC)
June 29, 2021
From
Vedanta Biosciences
Via
Business Wire
PureTech Founded Entity Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
June 23, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Adds Inflammatory Disease Candidates To Pipeline With Alivio Buyout
June 16, 2021
Four years after launching Alivio Therapeutics, PureTech Health plc (NASDAQ: PRTC) is bringing the hydrogel player back into the fold by acquiring the...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
June 16, 2021
Gainers Orphazyme (NASDAQ:ORPH) shares moved upwards by 72.49% to $17.34 during Wednesday's regular session. As of 12:31 EST, Orphazyme's stock is trading at a...
Via
Benzinga
PureTech Acquires Remaining Interest in Founded Entity Alivio Therapeutics
June 16, 2021
From
PureTech Health plc
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Intraday Session
June 03, 2021
Gainers Kindred Biosciences (NASDAQ:KIN) shares increased by 24.08% to $6.75 during Thursday's regular session. Kindred Biosciences's stock is trading at a volume...
Via
Benzinga
Results of Annual General Meeting
May 27, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis Presents Findings on Plenity®-Induced Weight Loss at the American Association of Clinical Endocrinology (AACE) 2021 Annual Virtual Meeting
May 27, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Secures $160 Million in Financing; Poised to Deliver on the Promise of Digital Therapeutics
May 26, 2021
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Jefferies Virtual Healthcare Conference
May 25, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Forms Clinical Advisory Board for Idiopathic Pulmonary Fibrosis and Related Lung Disorders
May 12, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Announces Nature Publication Supporting Modulation of Meningeal Lymphatics to Target Alzheimer’s Disease Pathologies
April 28, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Gelesis Appoints Procter & Gamble Veteran Jane Wildman to Board of Directors
April 26, 2021
From
PureTech Health plc
Via
Business Wire
Vedanta Biosciences to Present at the 2021 Jefferies Virtual Microbiome-Based Therapeutics Summit
April 15, 2021
From
Vedanta Biosciences
Via
Business Wire
Earnings Scheduled For April 15, 2021
April 15, 2021
Companies Reporting Before The Bell • Charles Schwab (NYSE:SCHW) is projected to report quarterly earnings at $0.82 per share on revenue of $4.58 billion. •...
Via
Benzinga
PureTech Announces Annual Results for Year Ended December 31, 2020
April 15, 2021
From
PureTech Health plc
Via
Business Wire
PureTech Presents Promising Preclinical Data from LYT-210 Immuno-Oncology Program at American Association for Cancer Research (AACR) Annual Meeting
April 12, 2021
From
PureTech Health plc
Via
Business Wire
PureTech to Present at Two Upcoming Investor Conferences
April 07, 2021
From
PureTech Health plc
Via
Business Wire
Stocks That Hit 52-Week Highs On Thursday
April 08, 2021
Thursday morning saw 168 companies set new 52-week highs. Intriguing Points: Microsoft (NASDAQ:MSFT) was the largest company by market cap to set a new 52-week high...
Via
Benzinga
PureTech Founded Entity Akili Collaborates with Weill Cornell Medicine, NewYork-Presbyterian Hospital and Vanderbilt University Medical Center to Study Digital Therapeutic AKL-T01 as Potential Treatment for Patients with COVID Brain Fog
April 07, 2021
From
PureTech Health plc
Via
Business Wire
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.